EcoR1 Capital, LLC 13D and 13G filings for Spyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:37 pm Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | EcoR1 Capital, LLC | 887,076 2.500% | 887,076 (New Position) | Filing |